CRISPR Therapeutics AG (CRSP)
Nasdaq: CRSP · Biological Products, (No Diagnostic Substances) · Zug · filing with the SEC since 2016
Who runs CRISPR Therapeutics AG
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kulkarni Samarth
Chief Executive Officer. First filing Oct 2016, latest Oct 28, 2026, 49 filings in all.
Officers reporting now
6
of 16 people with a filing in the last fifteen months
Directors reporting now
10
31 people on the record since 2016
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Sakhamuri Sivakesava | Chief Technical Officer | Nov 2026 | Nov 6, 2026 | none |
| Kulkarni Samarth | Chief Executive Officer | Oct 2016 | Oct 28, 2026 | 9 · $9.6M |
| Silver Andrew Jacob | Chief Financial Officer | Oct 2026 | Oct 28, 2026 | none |
| Patel Naimish | Chief Medical Officer | May 2024 | Oct 28, 2026 | 2 · $400,000 |
| Kasinger James R. | General Counsel and Secretary | Jun 2017 | Oct 28, 2026 | 7 · $1.4M |
| Prasad Raju | Chief Financial Officer | Mar 2023 | Aug 11, 2026 | 10 · $5.1M |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| George Simeon | director | Oct 2016 | Oct 16, 2026 | 1 · $700,000 |
| Behbahani Ali | director | Oct 2016 | Sep 21, 2026 | 1 · $800,000 |
| Fardis Maria | director | Jun 2022 | Jun 9, 2026 | none |
| Fleming Harold Edward | director | Jun 2021 | Jun 9, 2026 | none |
| Greene John | director | Jun 2019 | Jun 9, 2026 | none |
| High Katherine A | director | Jun 2019 | Jun 9, 2026 | none |
| Mahatme Sandesh | director | May 2024 | Jun 9, 2026 | none |
| Morrison Briggs | director | Jun 2025 | Jun 9, 2026 | none |
| Rommel Christian | director | May 2024 | Jun 9, 2026 | none |
| Treco Douglas A | director | Jun 2020 | Jun 9, 2026 | none |
Earlier names on the record31, newest filing first
Bruno Julianne · officer · last filing Mar 2025Morrow Phuong Khanh · officer · last filing Oct 2023Smith Brendan · officer · last filing Feb 2023Klein Lawrence Otto · officer · last filing Aug 2022Bolzon Bradley J Phd · director · last filing Jun 2022Ho Tony W · officer · last filing Dec 2021Tomsicek Michael John · officer · last filing Aug 2021Novak Rodger · officer · last filing Jul 2021Cagnoni Pablo J · director · last filing Nov 2019Emster Kurt Von · director · last filing Jan 2019Vertex Pharmaceuticals (Europe) Ltd · 10% owner · last filing Dec 2018Vertex Pharmaceuticals Inc / Ma · 10% owner · last filing Dec 2018Woiwode Thomas · director · last filing Jun 2018Versant Affiliates Fund V, L.P. · 10% owner · last filing Apr 2018Versant Ophthalmic Affiliates I, L.P. · 10% owner · last filing Apr 2018Versant Venture Capital V (Canada), LP · 10% owner · last filing Apr 2018Versant Venture Capital V, L.P. · 10% owner · last filing Apr 2018Versant Ventures V, LLC · 10% owner · last filing Apr 2018Versant Side Fund IV, L.P. · 10% owner · last filing Apr 2018Versant Venture Capital IV, L.P. · 10% owner · last filing Apr 2018Versant Ventures IV, LLC · 10% owner · last filing Apr 2018Bayer Aktiengesellschaft · 10% owner · last filing Jan 2018Bayer Global Investments B.V. · 10% owner · last filing Jan 2018Dylan-Hyde Tyler · officer · last filing Jan 2018Celgene Corp /de/ · 10% owner · last filing Dec 2017Versant Ventures V (Canada), L.P. · 10% owner · last filing Sep 2017Subramanian Kala · officer · last filing Jun 2017Coles N Anthony · director · last filing Jun 2017Lundberg Sven Ante · officer · last filing Feb 2017Glaxosmithkline PLC · 10% owner · last filing Oct 2016Hadley Harbor Master Investors (Cayman) L.P. · 10% owner · last filing Oct 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.